The global race is on to develop a vaccine against COVID-19. While it usually takes many years to develop and widely distribute vaccines, scientists around the world are now trying to get one ready within the next year — an unprecedented time frame.
The race has generated fierce competition among countries, as everyone wants to develop a vaccine on their home turf first, not only for prestige, but also to get their citizens at the front of the line for the shots when they are available. Still, while the scientific world is now rife with geopolitical rivalries over the COVID-19 vaccine, there's also a lot of international collaboration going on behind the scenes. Here's a look at the vaccines currently in Phase II of the clinical trial process, meaning they are being tested on hundreds of people of various age groups to determine their effectiveness and safety. If they pass this stage they move to wider testing in Phase III, the final step before approval.
More For You
Ian Bremmer sits down with Ivan Krastev, Chairman of the Centre for Liberal Strategies and political scientist, to discuss Hungary's consequential upcoming election and what it means for the far right globally.
Most Popular
A new US regulatory framework sets clear rules for stablecoins, defining issuer responsibilities and laying the groundwork for consistent federal and state oversight. With guardrails in place, stablecoins are shifting from crypto experiment to payment infrastructure. Explore the stablecoin framework with Bank of America Institute.
See: “Raphael: Sublime Poetry at the Met.” The first Raphael retrospective ever mounted in the US is running through June 28 at the Met Museum.
Forty-eight countries have officially qualified for the World Cup, after Iraq booked the final spot with its win against Bolivia on Tuesday.
